Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 18, 2025 17:56 ET | Source: Robbins LLP

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT

Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
August 14, 2025 19:28 ET | Source: Robbins LLP

Robbins LLP Urges LINE Investors with Large Losses to Contact the Firm for Information About Leading the LINE Securities Fraud Class Action

Robbins LLP is Investigating Allegations that Lineage, Inc. (LINE) Misled Investors in Connection with its IPO
August 14, 2025 19:25 ET | Source: Robbins LLP

Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/S

Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled the Market About its 2025 Revenue and Profit Growth Potential
August 14, 2025 19:22 ET | Source: Robbins LLP

ANRO Investors: If You Have Suffered Large Losses Contact Robbins LLP for Information About Leading the Alto Neuroscience, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Alto Neuroscience, Inc. (ANRO) Misled Investors Regarding the Viability of its Drug Candidate
August 12, 2025 17:19 ET | Source: Robbins LLP

CTO Shareholder Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against CTO Realty Growth, Inc.

Robbins LLP is Investigating Allegations that CTO Realty Growth, Inc. (CTO) Misled Investors Regarding its Financial Prospects
August 11, 2025 19:21 ET | Source: Robbins LLP

Spectrum Pharmaceuticals, Inc. (SPPI) Investors: Contact Robbins LLP for Information About the Class Action Against Spectrum Pharmaceuticals, Inc.

Robbins LLP announces a class action against Spectrum Pharmaceuticals (SPPI) for alleged securities law violations tied to its cancer drug apaziquone.
August 11, 2025 19:00 ET | Source: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the SelectQuote, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that SelectQuote, Inc. (SLQT) Violated the False Claims Act
August 06, 2025 20:29 ET | Source: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Altimmune, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability of its IMPACT Phase 2b MASH Trial
August 05, 2025 22:07 ET | Source: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Novo Nordisk A/S Class Action Lawsuit

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (NYSE: NVO)...
August 05, 2025 20:03 ET | Source: Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit

Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit